|Table 5: Reasons why clinicians reported ordering specific cancer genomics tests in the past 12 months, among clinicians who ordered the genetic tests.|
aThe column % reflects the percent responding within each practice category.|
bCI: confidence interval.
cBC: breast cancer.
dOC: ovarian cancer.
eAmong clinicians who recommend breast and ovarian screening to patients without breast cancer.
fAmong clinicians who treat breast and ovarian cancer.
gSpecifically testing for mismatch repair (MMR) genes, which may include testing in MCH1, MSH2, MSH6, and PMS2 genes.
hCRC: colorectal cancer.
iAmong clinicians who recommend colorectal cancer screening to patients without colorectal cancer.
jAmong clinicians who treat colorectal cancer.
kFor Lynch syndrome testing for patients with cancer, the phrasing was “guide chemotherapeutic treatment decisions.”